Surgery Partners, Inc.
Surgery Partners, Inc.（SGRY）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
sgry · 股价预测 · 22 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 22 位华尔街分析师
Buy
22 位分析师
共识
评级分布
12 个月目标价
High
$21.00
Consensus
$19.25
+40.4% upside
Low
$17.00
Median: $19.5 · Last Close: $13.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.25
40.4% upside
High Target
$21
53.2%
Low Target
$17
24.0%
Current Price
$13.71
as of today
Based on analyst price targets, the SGRY stock price prediction for the next 12 months ranges from $17 to $21. The consensus SGRY price forecast of $19.25 implies 40.4% upside from the current price of $13.71.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $13.61 | ↓ 0.70% |
1-day model range: $13.56–$13.66. Peak: $13.66 (-0.70%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -40.3% |
| 2028 | $6 | -53.6% |
| 2029 | $6 | -59.2% |
| 2030 | $5 | -62.0% |
| 2031 | — | -63.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SGRY · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-05 | TD Cowen | Maintains | Buy→Buy |
| 2026-03-05 | UBS | Maintains | Buy→Buy |
| 2026-03-05 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-04 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-03 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2025-12-18 | Mizuho | Maintains | Outperform→Outperform |
| 2025-11-24 | JP Morgan | Maintains | Neutral→Neutral |
| 2025-11-21 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2025-11-17 | Mizuho | Maintains | Outperform→Outperform |
| 2025-11-13 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Surgery Partners, Inc. (SGRY) stock. Of the recent 118 rating actions, 8 were upgrades and 12 were downgrades. 22 analysts currently cover SGRY.
分析师推荐趋势
SGRY analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3.3B
↓ 8.3% YoY
Revenue Next Year
$3.4B
↑ 3.6% YoY
EPS This Year
$0.63
EPS Next Year
$0.41
↓ 34.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast SGRY EPS of $0.63 for the current fiscal year, based on estimates from 7 analysts. The SGRY revenue forecast is $3.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SGRY 股价预测由两类独立数据源支撑：来自 22 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SGRY 的共识目标价为 $19.25（+40.4% 上行空间），分析师共识为 Buy。
SGRY 的短期预测（明日）为 $13.61（-0.70%）。 SGRY 对 2027 年的股价预测均值为 $8。 SGRY 对 2030 年的预测区间为 $5–$5。
Surgery Partners, Inc. 在 NASDAQ 上市，代码 SGRY。SGRY 在 2027 年的整体展望偏积极，在覆盖分析师中约 64% 对应 Buy 共识。
常见问题
SGRY 预测 · 8 个问题根据 22 位华尔街分析师，SGRY 的 12 个月平均目标价为 $19.25，最高 $21.00、最低 $17.00。若有图表，中位目标价可在上方查看。相对当前价 $13.71，隐含约 +40.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.